Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448597) titled 'Progesterone Preeclampsia' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Medical University of South Carolina

Condition: Preeclampsia Hypertensive Disorder of Pregnancy

Intervention: Drug: Progesterone supplementation

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: May 1, 2026

Target Sample Size: 642

To know more, visit https://clinicaltrials.gov/study/NCT07448597

Published by HT Digital Content Services with permission from Heal...